UniSa - IRIS Institutional Research Information System

SABBATINO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.809
EU - Europa 1.239
AS - Asia 991
SA - Sud America 142
AF - Africa 13
OC - Oceania 6
Totale 4.200
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.793
SG - Singapore 424
IT - Italia 354
RU - Federazione Russa 281
CN - Cina 223
DE - Germania 163
BR - Brasile 135
IE - Irlanda 98
TR - Turchia 94
VN - Vietnam 91
FI - Finlandia 65
SE - Svezia 65
UA - Ucraina 64
KR - Corea 48
AT - Austria 46
HK - Hong Kong 37
IN - India 32
NL - Olanda 28
CZ - Repubblica Ceca 23
FR - Francia 16
GB - Regno Unito 15
CA - Canada 8
NP - Nepal 8
PL - Polonia 7
UZ - Uzbekistan 6
JP - Giappone 5
MX - Messico 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
AL - Albania 3
IR - Iran 3
MA - Marocco 3
PK - Pakistan 3
ZA - Sudafrica 3
AR - Argentina 2
AU - Australia 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
IQ - Iraq 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
MY - Malesia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
EC - Ecuador 1
ES - Italia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
MM - Myanmar 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
VE - Venezuela 1
Totale 4.200
Salva come PNG Salva come JPEG
Città #
Ann Arbor 377
Chandler 304
Princeton 274
Singapore 140
Munich 105
Dublin 94
Dong Ket 91
Izmir 91
Jacksonville 88
Naples 86
Ashburn 74
Moscow 72
Wilmington 69
Beijing 61
Andover 56
Pellezzano 52
Houston 48
Helsinki 42
Nuremberg 40
Hong Kong 37
Nanjing 32
Salerno 31
Vienna 31
Woodbridge 30
Boardman 27
Los Angeles 25
Brno 23
Fairfield 19
Pune 17
Changsha 16
Nanchang 16
Norwalk 14
Sarno 12
Dallas 11
Lappeenranta 10
Milan 10
Paris 10
Fisciano 9
Amsterdam 8
Jiaxing 8
San Diego 8
Shanghai 8
Domicella 7
Kathmandu 7
Orange 7
Seattle 7
Shenyang 7
Warsaw 7
Cambridge 6
Hebei 6
Jyväskylä 6
Washington 6
Council Bluffs 5
New York 5
Redwood City 5
São Paulo 5
Toronto 5
Zhengzhou 5
Belo Horizonte 4
Cellole 4
Chiang Mai 4
Dearborn 4
Mercato San Severino 4
Rio de Janeiro 4
San Gennaro Vesuviano 4
Shijiazhuang 4
Stella Cilento 4
Tashkent 4
The Dalles 4
Tianjin 4
Auckland 3
Bologna 3
Carbonara di Nola 3
Delhi 3
Florence 3
Guarulhos 3
Jinan 3
Manassas 3
Mumbai 3
Porto Alegre 3
Prineville 3
Shenzhen 3
St Petersburg 3
Tirana 3
Aiello Del Sabato 2
Atrani 2
Aversa 2
Baghdad 2
Baltimore 2
Betim 2
Bishkek 2
Brasília 2
Cairo 2
Caserta 2
Chandigarh 2
Cuiabá 2
Desio 2
Draper 2
Düsseldorf 2
Edinburgh 2
Totale 2.794
Salva come PNG Salva come JPEG
Nome #
Abstract 3132: Single nucleotide polymorphisms (SNPs) in PD-L1 as predictive biomarkers for checkpoint inhibitor based-immunotherapy in caucasian patients with advanced NSCLC 214
Antitumor activity of BRAF inhibitor and IFN×alpha; Combination in BRAF-mutant melanoma 105
Cell growth-inhibition and cell cycle perturbations induced by a new synthetic iminoquinone, 5H-pyridophenoxazin-5-one, in human breast carcinoma cell lines. 104
Inhibition of NF-kB activity potentiates ionizing radiation and cisplatin induced cell killing of anaplastic thyroid carcinoma cells AACR Meeting Abstracts, Apr 2006; 2006: 1038. 102
The farnesyltransferase inhibitor R115777 (Zanestra) synergizes with ionizing radiation in inducing cell cycle perturbation and growth inhibition of human epidermoid head and neck cancer cells. 95
Counteracting resistance to treatments in solid tumors. 85
Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma 85
Abstract 3703: PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation 74
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2011. September 10-14, 2011. Munich, Germany 73
Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase i inhibitor or radiation 72
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2010. October 2-6, 2010. Valencia, Spain 70
PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation. 69
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC 66
Abstract 3639: Combinatorial therapy for triple negative breast cancer 65
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors 65
Abstract 4741: Inhibition of TNBC cell growth by CSPG4-specific mAb 225.28 with a Sonic Hedgehog pathway inhibitor 60
Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells 60
Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients 60
The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology 60
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer 57
597 IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 56
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma 56
Blocking the formation of radiation-induced breast cancer stem cells 55
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 54
Variability in immune infiltrates and HLA expression in cholangiocarcinoma 53
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 53
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 53
Multidisciplinary approach to patient with malignant melanoma 50
"Idealized" vs. "true" learning curves: The case of laparoscopic liver resection 49
P.1.279: ADVANCED HCC ABLATION AFTER DOWSTAGING WITH SORAFENIB 47
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients 47
Epigenetic control of gene expression: Potential implications for cancer treatment 46
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells 45
Ipilimumab in the treatment of metastatic melanoma: Management of adverse events 45
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 44
PD-L1 Dysregulation in COVID-19 Patients 44
Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma 43
Emerging BRAF inhibitors for melanoma 43
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers 42
Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma 41
Identification of Drug Interaction Adverse Events in Patients with COVID-19: A Systematic Review 41
Ki67 in Gleason Pattern 3 as a Marker of the Presence of Higher-Grade Prostate Cancer 40
PHH3 immunostaining: a novel prognostic biomarker in pancreatic neuroendocrine tumors 39
P.1.159: REPEATED LOCO-REGIONAL TREATMENTS: HIGH SURVIVAL RATES IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA HIGHLY COMPLIANT TO SCHEDULED FOLLOW-UP 39
Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature 39
Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy? 38
Genetic evolution of T-cell resistance in the course of melanoma progression 38
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer 38
Immune Checkpoint Inhibitors in Melanoma and HIV Infection 37
Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors 37
Diagnosis of Langerhans cell histiocytosis on cytological examination of cerebrospinal fluid: Report of the first case 36
Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review 36
Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives 36
Effect of tocilizumab in reducing the mortality rate in covid-19 patients: A systematic review with meta-analysis 36
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches 35
XXV Conferenza Nazionale di Citometria: CELL GROWTH INHIBITION AND CELL CYCLE PERTURBATIONS INDUCED BY A NEW SYNTHETIC IMINOQUINONE, 5H-PYRIDOPHENOXAZIN-5-ONE, IN HUMAN BREAST CARCINOMA CELL LINES 35
rs822336 as a predictive biomarker for anti-PD-1/PD-L1 immunotherapy in advanced NSCLC: Unraveling molecular mechanisms 34
Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors 34
A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation 34
XXV Conferenza Nazionale di Citometria: INHIBITION OF POLY (ADP-RIBOSE) POLYMERASE SYNERGIZES WITH THE DNA-TOPOISOMERASE-1-INHIBITOR, TOPOTECAN, AND RADIATION IN HUMAN GLIOBLASTOMA CELL LINE 32
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC 31
Harnessing host innate immunity may combat acquired resistance to BRAFi 31
Testing egfr with idylla on cytological specimens of lung cancer: A review 31
Proceedings of the XXII National Conference of the Italian Society of Cytometry GIC, October 4–8, 2005, San Bendetto del Tronto (AP), Italy 30
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram 30
The ratio of grzb+ − foxp3+ over cd3+ t cells as a potential predictor of response to nivolumab in patients with metastatic melanoma 30
Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic Cholangiocarcinoma 29
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 29
P.1.112: IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 28
Immune checkpoint inhibitors for the treatment of melanoma 28
Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy 27
Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy 26
Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review 26
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19 25
Melanoma initiating cells: where do we stand? 25
PD-L1 and HLA class i antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma 25
Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy, Cancer Initiating Cells and Disease Recurrence 25
Novel combinatorial therapy for pancreatic adenocarcinoma 25
Tissue micro arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma 24
Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells 24
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors 24
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy 23
Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation 23
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy 23
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors 22
KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies 21
An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy 21
Monoclonal antibody-based immunotherapy of ovarian cancer: Targeting ovarian cancer cells with the B7-H3-specific mAb 376.96 21
Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors 21
The Current and Future Impact of Lymph Node Fine-Needle Aspiration Cytology on Patient Care 19
High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease 18
Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study 16
Cytopathological differential diagnosis of malignant tumor cells in the cerebrospinal fluid: A retrospective analysis 15
BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer 15
Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study 15
Clinical and genetic drivers of oligo-metastatic disease in colon cancer 14
Back to the Bench: Unveiling the Tissue Context is Crucial to Enhance the Efficacy of Agnostic Therapies in Oncology 14
Advancing the integration of biosignal-based automated pain assessment methods into a comprehensive model for addressing cancer pain 14
From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies 13
Interplay between B7–H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma 13
Totale 4.255
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.985
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.985
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202096 0 0 0 0 0 0 0 0 0 0 87 9
2020/2021226 10 7 13 7 10 19 21 3 7 1 20 108
2021/2022462 7 0 2 1 22 5 2 19 79 50 66 209
2022/2023752 77 80 68 128 55 144 1 48 98 1 42 10
2023/2024555 41 42 37 37 37 59 44 29 35 37 29 128
2024/20251.385 44 17 28 66 90 195 322 138 335 141 9 0
Totale 4.466